The DOI matches its Crossref record.
The Efficacy and Safety of Venlafaxine in the Prophylaxis of Migraine
Abstract
Objective.—To evaluate the efficacy and safety of venlafaxine in the prophylaxis of migraine. Background.—The efficacy of venlafaxine, which is selectively effective on the serotonergic and noradrenergic mechanisms, on various headaches and chronic pain syndromes has been demonstrated. To our knowledge, this is the first placebo‐controlled, double‐blind, randomized study of two different doses of venlafaxine for migraine treatment. Methods.—In this prospective study, 60 migraine patients without aura were randomly assigned to venlafaxine XR 75 mg, venlafaxine XR 150 mg, or placebo. The frequency of headache attacks, the severity and the duration of attacks, and analgesic use were monitored every 2 weeks for 2 months. Adverse events and patient satisfaction were also evaluated during these visits. At the end of the 2 months, global efficacy and tolerance were investigated. Results.—A significant difference was observed between the venlafaxine 150 mg and placebo groups in the number of headache attacks ( P = .006). According to patient satisfaction comparisons, the active drug groups were significantly different when compared with placebo ( P = .001 at visit 2 and visit 6). When the global efficacy was considered, 80% of patients in the 75‐mg group and 88.2% of the patients in the 150‐mg group evaluated treatment benefits as either good or very good. Conclusions.—Venlafaxine was more effective than placebo and is safe and well tolerated as migraine prophylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Idiopathic intracranial hypertension: consensus guidelines on management
Mollan, S. P., Davies, B., Silver, N. C., Shaw, S., Mallucci, C. L., Wakerley, B. R., Krishnan, A., Chavda, S. V., Ramalingam, S., Edwards, J., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317440 · Cited by 612
Efficacy of Antidepressants as Analgesics: A Review
Dharmshaktu, P., Tayal, V., & Kalra, B. S. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394852 · Cited by 326
Silberstein, S. D. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2008.11.007 · Cited by 299
Metadata
- Authors
- Ozyalcin, S. N., Talu, G. K., Kiziltan, E., Yucel, B., Ertas, M., & Disci, R.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2005-02
- Volume
- 45
- Issue
- 2
- Pages
- 144-152
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2164288068
- Cited by
- 229
- References
- 0
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Efficacy and Safety of Venlafaxine in the Prophylaxis of Migraine. https://app.cochat.ai/papers/10.1111/j.1526-4610.2005.05029.x
- The paper
- Ozyalcin, S. N., Talu, G. K., Kiziltan, E., Yucel, B., Ertas, M., & Disci, R. (2005). The Efficacy and Safety of Venlafaxine in the Prophylaxis of Migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2005.05029.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.